KI-Beratung Beta

Produktbild: Natural Product Drug Discovery
- 13%

Natural Product Drug Discovery Highly Anticipated Natural Molecules

Aus der Reihe Drug Discovery Opinions
13% sparen

165,99 € UVP 191,20 €

inkl. gesetzl. MwSt., Versandkostenfrei


Beschreibung

Natural Product Drug Discovery: Highly Anticipated Natural Molecules, a new volume in the Drug Discovery Opinion series, provides a comprehensive examination of the role of natural products in innovative drug development. The book addresses the significant challenges that highly active natural molecules...

Beschreibung

Natural Product Drug Discovery: Highly Anticipated Natural Molecules, a new volume in the Drug Discovery Opinion series, provides a comprehensive examination of the role of natural products in innovative drug development. The book addresses the significant challenges that highly active natural molecules face in the drug development process, including issues related to bioavailability and potency. Sections present analyses of various classes of natural products, including polysaccharides, volatile oils, and diterpenoids, exploring their chemical properties, biological activities, and potential clinical applications. Each chapter, written by leading experts, offers insights into structural modification techniques, naturally sourced inhibitors, and the application of green biomanufacturing strategies.
It will serve as an essential resource for researchers, pharmacologists, and industry professionals involved in natural product drug discovery. Readers will find the necessary information to navigate the complexities of the field, emphasizing the integration of traditional knowledge with modern scientific approaches. Through a thorough understanding of these natural compounds, this book aims to contribute to the advancement of therapeutic innovations in pharmacotherapy.

Portrait

Professor Ning Li is the associate dean of Chinese Materia Medica of Shenyang Pharmaceutical University, the "Youth talent" of Liao Ning Revitalization Talents Program, the "Talent of Hundred level" of Liaoning Bai Qian Wan Talents Program, the "Leading talent" of both Shenyang High-Level Talent Program and Xinjiang Uygur Autonomous Region. She has focused on the research of chemoprevention of critical diseases, especially the neurodegenerative disease and cancer, through post-transcriptional mechanism on the perspective view of 'preventive treatment strategy' of the Traditional Chinese theory. She has hosted seven projects of National Natural Science Foundation of China and published more than 120 SCI papers on famous academic journals, born several prizes like the "First Prize of Provincial Science and technology progress award", and obtained the authorization of 20 invention patents.Professor Yang Liu, currently serves as the Dean of the School of Pharmaceutical Engineering, the Chairman of the Pharmaceutical Engineering Discipline and the Chairman of the Biology and Medicine Discipline at Shenyang Pharmaceutical University, P. R. China. He received his Bachelor and Master Degrees from Hunan University, and Doctoral Degree from Shenyang Pharmaceutical University. Professor Liu has been engaged in innovative research of medicinal chemistry for a long time, leading his group to carry out researches on innovative drugs and modified new drugs for treatment of malignant tumors, diabetes, AD and other major diseases, developing drug preparation technologies suitable for industrial production, and promoting the industrialization of project implementation. He has published over 120 research papers, authored 8 books, and applied for 18 invention patents. He has been selected into the Outstanding Young Scholars in Liaoning Province and the Innovative Talents in Liaoning Province, and has won the first prize for science and technology progresses in Liaoning Province.

Produktdetails

Einband

Taschenbuch

Erscheinungsdatum

01.02.2026

Herausgeber Ning Li + weitere
Verlag Elsevier Science & Technology

Produktdetails

Einband

Taschenbuch

Erscheinungsdatum

01.02.2026

Herausgeber
Verlag Elsevier Science & Technology
Seitenzahl

472

Maße (B/H)

21,5/27,6 cm

Gewicht

450 g

Sprache

Englisch

ISBN

978-0-443-40578-5

EU-Ansprechpartner

Elsevier B.V.
Radarweg 29
1043 NX Amsterdam
NL
productsafety@elsevier.com

Herstelleradresse

Elsevier Science & Technology
London Wall 125
EC2Y 5AS London
GB
tradeorders@elsevier.com

Noch keine Bewertungen vorhanden

Verfassen Sie die erste Bewertung zu diesem Artikel

Helfen Sie anderen Kundinnen und Kunden durch Ihre Meinung.

Kundinnen und Kunden meinen

Bewertungen (0)

  • Produktbild: Natural Product Drug Discovery
  • 1. Highly Anticipated Natural Molecules
    2. The Key Technology in Drug Discovery: Structural Modification of Natural Products
    3. Naturally Sourced Sodium-Glucose Co-transporter 2 Inhibitors for Hypoglycemic: From Phlorizin to Dapagliflozin
    4. Polysaccharides from TCM as an Important Resource of New Drugs for Antiosteoporosis and Neurodegenerative Diseases
    5. Drug Discovery from Daphnane-type Diterpenoids: A Balance Between the Anti-HIV Effect and Toxicity
    6. The Promising Future of Sesquiterpenoids: A Potential Source of New Drugs
    7. Tussilagone as a Potential Therapeutic Candidate Against Inflammation-Related Diseases
    8. Right Time for Drug Development from Volatile Oils
    9. Natural Products in Alzheimer's Disease
    10. The Discovery, Synthesis, and Bioactivities of Marine Sesquiterpene Hydroquinones/Quinones
    11. Cardiac Glycoside: A Potential Antineoplastic Candidate from a Medication of Heart Failure and Atrial Arrhythmia
    12. Natural Products as Potential Neuroprotective Agents for Ischemic Stroke
    13. Key Strategy for Drug Development: Green Biomanufacturing of Active Natural Products
    14. Research and Development of the Anti-Tumor Star Molecule Taxol
    15. Bile Acids: Dual Facets as Modulators and Targets in Natural Product Drug Discovery
    16. Natural Cephalotane Alkaloids from Cephalotaxaceae as a Source of New Anticancer Drugs
    17. Computation-Enabled Natural Products Drug Discovery
    18. Active Metabolites Derived from Microorganisms of Extreme Environments